Product Images Enalaprilat
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Enalaprilat NDC 51662-1477 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Enalaprilat injection, USP is not recommended for use during the 2nd and 3rd trimesters of pregnancy as it may result in harm or death to the developing fetus. When pregnancy is detected, this medication should be stopped immediately. More details and warnings can be found in the section labeled "Fetal/Neonatal Morbidity and Mortality."*
This is a description of a pharmaceutical product. It is Enalaprilat injection, USP, intended for IV use only. The NDC is 0143-9787-01 and the lot number is 1903097.1. The manufacturer's package insert should be consulted before use. The product is distributed by HF Acquisition Co. located in Mukilteo, Washington. The text also includes prescription use indications and dosage information but it is difficult to interpret due to errors in the .*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.